Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
erythro-N-Boc-D-phenylalanine epoxide → [(1R,2S)-3-Benzotriazol-2-yl-1-benzyl-2-hydroxy-propyl]-carbamic acid tert-butyl ester
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | erythro-N-Boc-D-phenylalanine epoxide | HCID 11357515 | — |
| 반응물 | HCID 178418385 | HCID 178418385 | — |
| 생성물 | [(1R,2S)-3-Benzotriazol-2-yl-1-benzyl-2-hydroxy-propyl]-carbamic acid tert-butyl ester | HCID 66703744 | — |
반응 단계
Using general procedure 4 and purification method E (elute with isocratic 20% ethyl acetate/hexanes in this case) with [(1R)-1-{(2R)-oxiran-2-yl}-2-phenyl-ethyl]carbamic acid tert-butylester (0.25 g, 0.95 mmol) and 1,2,3-benzotriazole (0.136 g, 1.14 mmol) gives the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08106090B2 |
| 출처 데이터셋 | uspto-grants-2012_01 |
| ORD ID | ord-23e1f0bcd1424293a0868236f64b31a0 |
| 출처 메모 | uspto-grants-2012_01 |